Crinetics Pharmaceuticals, Inc. · NASDAQ:CRNX
Struthers Richard Scott disposed of 1,069,611 Crinetics Pharmaceuticals, Inc. shares (Form 4)
Traded Sep 1, 2026 · Filed Sep 1, 2026
On Sep 1, 2026, Struthers Richard Scott (Director, President & CEO) disposed of 1,069,611 Crinetics Pharmaceuticals, Inc. shares at US$85.00 for US$90.9M, leaving 0 shares. Filed Sep 1, 2026 (Form 4).
- Disposed of
- 1,069,611 shares
- Price
- US$85.00
- Value
- US$90.9M
- Holding after
- 0 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Disposition | 248,043 | US$85.00 | 176,663 | Direct |
| Sep 1, 2026 | Common Stock | Disposition | 1,000 | US$85.00 | 0 | Indirect |
| Sep 1, 2026 | Common Stock | Disposition | 136,805 | US$85.00 | 0 | Indirect |
| Sep 1, 2026 | Common Stock | Disposition | 106,000 | US$85.00 | 0 | Indirect |
| Sep 1, 2026 | Common Stock | Disposition | 110,000 | US$85.00 | 0 | Indirect |
| Sep 1, 2026 | Common Stock | Disposition | 100,000 | US$85.00 | 0 | Indirect |
| Sep 1, 2026 | Common Stock | Disposition | 111,100 | US$85.00 | 0 | Indirect |
| Sep 1, 2026 | Common Stock | Disposition | 80,000 | US$85.00 | 0 | Indirect |
| Sep 1, 2026 | Common Stock | Disposition | 176,663 | US$85.00 | 0 | Direct |
Source
Related
- Crinetics Pharmaceuticals, Inc.
- Struthers Richard Scott
- Crinetics Pharmaceuticals, Inc. shareholders
- Form 4 · Struthers Richard Scott · Aug 11, 2026
- Form 4 · Struthers Richard Scott · Jun 2, 2026
- Form 4 · Wierenga Wendell · Sep 1, 2026
- Form 4 · Vivaldi Coelho Rogerio · Sep 1, 2026
- Form 4 · Okey Stephanie · Sep 1, 2026
- Form 4 · Nichols Weston · Sep 1, 2026
- Form 4 · Fust Matthew K · Sep 1, 2026